Качественная клиническая практика (Oct 2020)

Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»

  • V. A. Otdelenov,
  • V. M. Tsvetov,
  • D. A. Sychev

DOI
https://doi.org/10.37489/2588-0519-2020-S4-11-14
Journal volume & issue
Vol. 0, no. 4S
pp. 11 – 14

Abstract

Read online

Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.

Keywords